Search alternatives:
marked decrease » marked increase (Expand Search)
mri decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
marked decrease » marked increase (Expand Search)
mri decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1
-
2
Data Sheet 1_Aging of visual word perception is related to decreased segregation within and beyond the word network in the brain.docx
Published 2024“…</p>Discussion<p>These results suggest that cognitive decline in visual word perception is associated with decreased segregation within and beyond the word network in the aging brain. …”
-
3
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
4
-
5
-
6
Biases in larger populations.
Published 2025“…Threshold parameter <i>c</i> = − 0 . 1 for the rectified cosine tuning with 4 neurons, and width <i>w</i> was 1 for von Mises tuning. …”
-
7
-
8
Cross-correlation analysis-the PFI signal precedes the gGM and CSF fMRI signals.
Published 2025Subjects: -
9
-
10
Coupled gGM and CSF fMRI signal changes induced by a transient hypercapnia challenge.
Published 2025Subjects: -
11
-
12
-
13
Coupled neuronal activity, gGM, PFI, and CSF fMRI signals during burst-suppression anesthesia.
Published 2025Subjects: -
14
-
15
-
16
-
17
Image 1_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.tiff
Published 2025“…The influx constant (K<sub>i</sub>) derived from dynamic contrast-enhanced MRI (DCE-MRI), a marker of blood–brain barrier (BBB) permeability, has shown promise as a predictor of disease activity in relapsing–remitting MS (RRMS).…”
-
18
-
19
-
20
Data Sheet 1_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf
Published 2025“…The influx constant (K<sub>i</sub>) derived from dynamic contrast-enhanced MRI (DCE-MRI), a marker of blood–brain barrier (BBB) permeability, has shown promise as a predictor of disease activity in relapsing–remitting MS (RRMS).…”